🔗 Visit the ClinicalTrials.gov page for NCT00774826
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Trial watch: Chemotherapy with immunogenic cell death inducers. | Oncoimmunology | 2012 | 1.33 |
| 2 | Anthracyclines: a cornerstone in the management of non-Hodgkin's lymphoma. | Hematol Rep | 2011 | 0.79 |
| 3 | Positron emission tomography response and minimal residual disease impact on progression-free survival in patients with follicular lymphoma. A subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi. | Haematologica | 2015 | 0.78 |
| 4 | The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL study. | Haematologica | 2015 | 0.75 |
| 5 | Clinical implications and prognostic role of minimal residual disease detection in follicular lymphoma. | Ther Adv Hematol | 2013 | 0.75 |
| 6 | Case studies of elderly patients with non-Hodgkin's lymphoma. | Hematol Rep | 2011 | 0.75 |